PREPRINT (not peer reviewed)

Level of Preparedness to Use Psilocybin Among Individuals Seeking Psychedelic Risk Reduction: A retrospective study of a pilot psychiatric consultation service

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: medRxiv
Date: 2026-08-19
Source: medRxiv
DOI: 10.64898/2026.08.17.26360633
PubMed: Unavailable

Authors

Harrison H. V.; Gaillard M.; Cook R. R.; Sarparast A.; Levander X. A.

Watch author

Derived topics and classifications

psilocybin Review Article Safety Adverse Events Review Article

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical PracticePharmacology Research & Perspectives · 2026-05-10 MedCheck: Psilocybin for Depression, LSD for Anxiety, Donanemab, LSD, and MorePsychiatric News · 2024-04-23 Altered stakes: Identifying gaps in the informed consent process for psychedelic-assisted therapy trialsJournal of Psychedelic Studies · 2023-11-20 The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.Journal of psychopharmacology (Oxford, England) · 2022-01-01 Psychiatry & the psychedelic drugs. Past, present & future.Neuropharmacology · 2018-11-01 Psychedelics and mental health: reimagining care through science, insight, and compassion.Frontiers in pharmacology · 2025-01-01 Enlightenment in a Pill-Testing the Efficacy of PsilocybinJAMA Psychiatry · 2026-05-01 Response of cluster headache to psilocybin and LSD.Neurology · 2006-06-27